[LXRX] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
01-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 20.73%
YoY- 10.45%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 9,682 9,216 17,071 6,856 13,753 25,207 33,047 -55.98%
PBT -23,018 -21,797 -16,781 -27,512 -34,706 -42,075 -32,387 -20.40%
Tax -219 789 -102 783 6,097 6,119 -4,009 -85.67%
NP -23,018 -21,797 -16,781 -27,512 -34,706 -42,075 -28,378 -13.05%
Tax Rate - - - - - - - -
Total Cost 32,700 31,013 33,852 34,368 48,459 67,282 61,425 -34.39%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -237.74 -236.51 -98.30 -401.28 -252.35 -166.92 -85.87 97.53%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.22 -0.21 -0.16 -0.26 -0.33 -0.40 -0.27 -12.79%
EPS Diluted -0.22 -0.21 -0.16 -0.26 -0.33 -0.40 -0.27 -12.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.